Cargando…

WNT6 is an effective marker for osteosarcoma diagnosis and prognosis

Wingless-Type MMTV Integration Site Family, Member 6 (WNT6) is a member of the Wnt family and its expression is abnormal in different human cancer cell lines. The purpose of this study was to investigate the clinical significance of WNT6 in osteosarcoma. The levels of WNT6 mRNA and protein in tissue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Kai, Li, Sha, Li, Lu, Wang, Xiaohua, Gu, Yuanjie, Jin, Zhiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257418/ https://www.ncbi.nlm.nih.gov/pubmed/30431574 http://dx.doi.org/10.1097/MD.0000000000013011

Ejemplares similares

Correlation study of DNA methylation of WNT6 gene with osteosarcoma in children
por: Li, Li, et al.
Publicado: (2017)

Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma
por: Diao, Zhen-bin, et al.
Publicado: (2020)

High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis
por: Zhu, Bin, et al.
Publicado: (2016)

Effect of Unplanned Therapy on the Prognosis of Patients with Extremity Osteosarcoma
por: Wang, Bing, et al.
Publicado: (2016)

EFEMP1 as a Potential Biomarker for Diagnosis and Prognosis of Osteosarcoma
por: Wang, Zhuo, et al.
Publicado: (2020)

Osteopontin as a biomarker for osteosarcoma therapy and prognosis
por: Han, Xingwen, et al.
Publicado: (2019)

Increased DEF6 expression is correlated with metastasis and poor prognosis in human osteosarcoma
por: Zhang, Qiao, et al.
Publicado: (2020)

DNA methylation markers in the diagnosis and prognosis of common leukemias
por: Jiang, Hua, et al.
Publicado: (2020)

Sevoflurane Inhibited Osteosarcoma Cell Proliferation And Invasion Via Targeting miR-203/WNT2B/Wnt/β-Catenin Axis
por: Chen, Meixian, et al.
Publicado: (2019)

Serum CEACAM1 Level Is Associated with Diagnosis and Prognosis in Patients with Osteosarcoma
por: Yu, Haiying, et al.
Publicado: (2016)

A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes
por: Tang, Haijun, et al.
Publicado: (2023)

Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in osteosarcoma
por: Jeddo, Salim F.A., et al.
Publicado: (2020)

Exosome-mediated Hic-5 regulates proliferation and apoptosis of osteosarcoma via Wnt/β-catenin signal pathway
por: Sha, Liansheng, et al.
Publicado: (2020)

The effect of pathological fractures on the prognosis of patients with osteosarcoma: a meta-analysis of 14 studies
por: Zhou, Yifei, et al.
Publicado: (2017)

Aberrant expression of SPAG6 and NM23 predicts poor prognosis of human osteosarcoma
por: Bao, Zhengqi, et al.
Publicado: (2022)

The genetic basis for inactivation of Wnt pathway in human osteosarcoma
por: Du, Xiaoling, et al.
Publicado: (2014)

Wnt signaling and Loxl2 promote aggressive osteosarcoma
por: Matsuoka, Kazuhiko, et al.
Publicado: (2020)

Characteristics and prognosis of primary pulmonary osteosarcoma: a pooled analysis
por: Huang, Weijia, et al.
Publicado: (2022)

Polymeric immunoglobulin receptor expression is correlated with poor prognosis in patients with osteosarcoma
por: WANG, XUANWEI, et al.
Publicado: (2014)

Tropomyosin Is Potential Markers for the Diagnosis and Prognosis of Bladder Cancer
por: Yan, Yunkun, et al.
Publicado: (2022)

Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma
por: He, Jieyu, et al.
Publicado: (2021)

Regulatory effects of microRNA-184 on osteosarcoma via the Wnt/β-catenin signaling pathway
por: Du, Zhenguang, et al.
Publicado: (2018)

TUFT1 Promotes Osteosarcoma Cell Proliferation and Predicts Poor Prognosis in Osteosarcoma Patients
por: Yu, Yao-Ping, et al.
Publicado: (2018)

Machine-Learning-Based m5C Score for the Prognosis Diagnosis of Osteosarcoma
por: Zhang, Haijie, et al.
Publicado: (2021)

Resveratrol inhibits canonical Wnt signaling in human MG-63 osteosarcoma cells
por: ZOU, YONGGEN, et al.
Publicado: (2015)

Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma
por: Li, Jianhao, et al.
Publicado: (2020)

Self-Renewal and Pluripotency in Osteosarcoma Stem Cells’ Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers
por: Martins-Neves, Sara R., et al.
Publicado: (2023)

Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
por: Hong, Weifeng, et al.
Publicado: (2020)

BAIAP2L2 promotes the proliferation, migration and invasion of osteosarcoma associated with the Wnt/β-catenin pathway
por: Guo, Hongting, et al.
Publicado: (2021)

Novel miRNA markers for the diagnosis and prognosis of endometrial cancer
por: Wang, Qian, et al.
Publicado: (2020)

Targeting the Wnt/β-catenin pathway in human osteosarcoma cells
por: Fang, Fang, et al.
Publicado: (2018)

High GNG4 predicts adverse prognosis for osteosarcoma: Bioinformatics prediction and experimental verification
por: Jiang, Xiaohong, et al.
Publicado: (2023)

SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT–receptor complex
por: Zhao, S-J, et al.
Publicado: (2018)

Expression of WNT-5a and ROR2 correlates with disease severity in osteosarcoma
por: LU, BEI-JI, et al.
Publicado: (2012)

RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma
por: Chen, Shijie, et al.
Publicado: (2022)

Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma
por: Fu, Yucheng, et al.
Publicado: (2018)

FOXO1 inhibits osteosarcoma oncogenesis via Wnt/β-catenin pathway suppression
por: Guan, H, et al.
Publicado: (2015)

Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker
por: Lui, Ka Yin, et al.
Publicado: (2017)

CCT6A is associated with CDC20, Enneking stage and prognosis in osteosarcoma, and its knockdown suppresses osteosarcoma cell viability and invasion
por: Wang, Ning, et al.
Publicado: (2023)

ALOX5AP suppresses osteosarcoma progression via Wnt/β-catenin/EMT pathway and associates with clinical prognosis and immune infiltration
por: Han, Guo-Dong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_27snj688j87crqj9q151s4qosq